We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Contamination Concerns Land Raritan Pharmaceuticals a Form 483
Contamination Concerns Land Raritan Pharmaceuticals a Form 483
January 8, 2013
Raritan Pharmaceuticals’ East Brunswick, N.J., plant received a one-page Form 483 regarding concerns that distributed lots of one of its consumer products might be contaminated with clostridium difficile bacteria.